NCT06941142 2025-04-23
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Not yet recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
BeBetter Med Inc
Haihe Biopharma Co., Ltd.
AstraZeneca